imatinib krka d.d. 400mg dispergovatelná tableta
krka, d.d., novo mesto, novo mesto array - 16298 imatinib-mesilÁt - dispergovatelná tableta - 400mg - imatinib
imatinib sandoz 100mg potahovaná tableta
sandoz s.r.o., praha array - 16298 imatinib-mesilÁt - potahovaná tableta - 100mg - imatinib
imatinib sandoz 400mg potahovaná tableta
sandoz s.r.o., praha array - 16298 imatinib-mesilÁt - potahovaná tableta - 400mg - imatinib
imatinib glenmark 100mg potahovaná tableta
glenmark pharmaceuticals s.r.o., praha array - 16298 imatinib-mesilÁt - potahovaná tableta - 100mg - imatinib
imatinib glenmark 400mg potahovaná tableta
glenmark pharmaceuticals s.r.o., praha array - 16298 imatinib-mesilÁt - potahovaná tableta - 400mg - imatinib
imatinib teva pharma 400mg potahovaná tableta
teva pharma b.v., haarlem array - 16298 imatinib-mesilÁt - potahovaná tableta - 400mg - imatinib
alunbrig
takeda pharma a/s - brigatinib - karcinom, plicní jiná než malobuněčná - antineoplastická činidla - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
imanivec 100mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 16298 imatinib-mesilÁt - potahovaná tableta - 100mg - imatinib
imanivec 100mg dispergovatelná tableta
krka, d.d., novo mesto, novo mesto slovinsko - 16298 imatinib-mesilÁt - dispergovatelná tableta - 100mg - imatinib
imanivec 400mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 16298 imatinib-mesilÁt - potahovaná tableta - 400mg - imatinib